Citigroup
RNA

Citigroup’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Citigroup’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-26,445
Closed -$496K – 7759
2014
Q4 		$496K Sell
26,445
-2,563
-9% -$36.4K ﹤0.01% 3895
2014
Q3 		$245K Buy
29,008
+4,408
+18% +$41.8K ﹤0.01% 4080
2014
Q2 		$311K Sell
24,600
-11,879
-33% -$96.4K ﹤0.01% 3775
2014
Q1 		$206K Buy
36,479
+11,343
+45% +$70.3K ﹤0.01% 4302
2013
Q4 		$117K Buy
25,136
+24,036
+2,185% +$110K ﹤0.01% 5135
2013
Q3 		$7K Buy
+1,100
New +$25.9K ﹤0.01% 6344

Citigroup's RNA Position: Q1 2015 in Review

Citigroup sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 26,445 shares — an estimated $496K sold.

Citigroup first reported a position in RNA in Q3 2013 and held it in 6 quarters. The position peaked at $496K in Q4 2014. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

  • Citigroup reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
  • Citigroup sold 26,445 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $496K.
  • Citigroup first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 6 quarters.
  • Citigroup's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $496K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.